ABIE:XETRA:XETRA-AXA IM ACT Biodiversity Equity UCITS ETF EUR(H) Acc (EUR)

ETF | Others |

Last Closing

USD 12.8

Change

0.00 (0.00)%

Market Cap

N/A

Volume

1.69K

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-11-17 )

ETFs Containing ABIE:XETRA

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 8.81% 52% F 55% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 8.81% 51% F 53% F
Trailing 12 Months  
Capital Gain 17.58% 63% D 64% D
Dividend Return N/A N/A N/A N/A N/A
Total Return 17.58% 62% D 62% D
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain 6.75% 53% F 53% F
Dividend Return 6.75% 52% F 51% F
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 8.44% 68% D+ 75% C
Risk Adjusted Return 80.01% 76% C+ 79% B-
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (EUR)

Quarterly Financials (EUR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

What to not like:

There is nothing we particularly dislike